BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19250683)

  • 1. The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients.
    Tranter R; Bell D; Gutting P; Harmer C; Healy D; Anderson IM
    J Affect Disord; 2009 Nov; 118(1-3):87-93. PubMed ID: 19250683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?
    Eker SS; Kirli S; Akkaya C; Cangur S; Sarandol A
    World J Biol Psychiatry; 2009; 10(4 Pt 2):400-8. PubMed ID: 19670086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for modulation of facial emotional processing bias during emotional expression decoding by serotonergic and noradrenergic antidepressants: an event-related potential (ERP) study.
    Kerestes R; Labuschagne I; Croft RJ; O'Neill BV; Bhagwagar Z; Phan KL; Nathan PJ
    Psychopharmacology (Berl); 2009 Mar; 202(4):621-34. PubMed ID: 18825371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No effects of antidepressants on negative symptoms in schizophrenia.
    Hinkelmann K; Yassouridis A; Kellner M; Jahn H; Wiedemann K; Raedler TJ
    J Clin Psychopharmacol; 2013 Oct; 33(5):686-90. PubMed ID: 23857309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder.
    Juckel G; Pogarell O; Augustin H; Mulert C; Müller-Siecheneder F; Frodl T; Mavrogiorgou P; Hegerl U
    J Clin Psychiatry; 2007 Aug; 68(8):1206-12. PubMed ID: 17854244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
    Crawford AA; Lewis S; Nutt D; Peters TJ; Cowen P; O'Donovan MC; Wiles N; Lewis G
    Psychopharmacology (Berl); 2014 Aug; 231(15):2921-31. PubMed ID: 24525810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emotion recognition processing as early predictor of response to 8-week citalopram treatment in late-life depression.
    Shiroma PR; Thuras P; Johns B; Lim KO
    Int J Geriatr Psychiatry; 2014 Nov; 29(11):1132-9. PubMed ID: 24706294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal prolactin values correlate with response to reboxetine treatment in major depression, but not with response to citalopram.
    Moeller O; Hetzel G; Michael N; Rothermundt M; Arolt V; Erfurth A
    Neuropsychobiology; 2005; 51(2):67-71. PubMed ID: 15741746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the selective monoamine reuptake inhibitors reboxetine and citalopram on visually-evoked event-related potentials in depressed patients.
    Hetzel G; Moeller O; Erfurth A; Michael N; Rothermundt M; Arolt V; Evers S
    Pharmacopsychiatry; 2004 Sep; 37(5):200-5. PubMed ID: 15470798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of reboxetine and citalopram on hand-motor function in patients suffering from major depression.
    Hegerl U; Mergl R; Henkel V; Pogarell O; Müller-Siecheneder F; Frodl T; Juckel G
    Psychopharmacology (Berl); 2005 Feb; 178(1):58-66. PubMed ID: 15316714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder.
    Aragona M; Bancheri L; Perinelli D; Tarsitani L; Pizzimenti A; Conte A; Inghilleri M
    Eur J Pain; 2005 Feb; 9(1):33-8. PubMed ID: 15629872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression.
    Andreoli V; Caillard V; Deo RS; Rybakowski JK; Versiani M
    J Clin Psychopharmacol; 2002 Aug; 22(4):393-9. PubMed ID: 12172339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition.
    Harmer CJ; Shelley NC; Cowen PJ; Goodwin GM
    Am J Psychiatry; 2004 Jul; 161(7):1256-63. PubMed ID: 15229059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effectiveness of reboxetine versus fluoxetine in patients with atypical depression: a single-blind, randomized clinical trial.
    Taner E; Demir EY; Cosar B
    Adv Ther; 2006; 23(6):974-87. PubMed ID: 17276965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acute antidepressant administration on negative affective bias in depressed patients.
    Harmer CJ; O'Sullivan U; Favaron E; Massey-Chase R; Ayres R; Reinecke A; Goodwin GM; Cowen PJ
    Am J Psychiatry; 2009 Oct; 166(10):1178-84. PubMed ID: 19755572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment effects of serotonergic and noradrenergic antidepressants on the intensity dependence of auditory ERP components in major depression.
    Linka T; Sartory G; Wiltfang J; Müller BW
    Neurosci Lett; 2009 Sep; 463(1):26-30. PubMed ID: 19616062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity of depression and response to antidepressants: GENPOD randomised controlled trial.
    Wiles NJ; Mulligan J; Peters TJ; Cowen PJ; Mason V; Nutt D; Sharp D; Tallon D; Thomas L; O'Donovan MC; Lewis G
    Br J Psychiatry; 2012 Feb; 200(2):130-6. PubMed ID: 22194183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine.
    Berlanga C; Flores-Ramos M
    J Affect Disord; 2006 Oct; 95(1-3):119-23. PubMed ID: 16782204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trial.
    Gougoulaki M; Lewis G; Nutt DJ; Peters TJ; Wiles NJ; Lewis G
    J Psychopharmacol; 2021 Aug; 35(8):919-927. PubMed ID: 33637001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT(1A)-receptor over-expressing mice: genotype and sex dependent responses to antidepressants in the forced swim-test.
    Günther L; Rothe J; Rex A; Voigt JP; Millan MJ; Fink H; Bert B
    Neuropharmacology; 2011 Sep; 61(3):433-41. PubMed ID: 21419787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.